Patent directory · USPTO A61K / A61P
Patents matching “The Regents of the University of California”
3,494 pharma patents match "The Regents of the University of California" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.
Quick answer
This filtered view shows 3,494 pharmaceutical patents matching "The Regents of the University of California" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.
Patent results
-
US 8026284
Enterically coated cystamine, cysteamine and derivatives thereof
granted -
US 8025891
Porin B (PorB) as a therapeutic target for prevention and treatment of infection by Chlamydia
granted -
US 8021644
Methods for measuring rates of reverse cholesterol transport in vivo, as an index of anti-atherogenesis
granted -
US 8022052
Inhibition of PPAR gamma expression by specific osteogenic oxysterols
granted -
US 8021673
Proteins with repetitive Bacterial-Ig-like (Big) domains present in Leptospira species
granted -
US 8022040
Hydroxyapatite-binding peptides for bone growth and inhibition
granted -
US 8017135
Lipid-drug conjugates for local therapy of eye diseases
granted -
US 8012739
Methods and compositions for the production of orthogonal tRNA-aminoacyl-tRNA synthetase pairs
granted -
US 8008510
Metalloprotein inhibitors
granted -
US 8008353
Methods for modulating macrophage proliferation using polyamine analogs
granted -
US 8007778
Use of calcium binding proteins to improve cardiac contractile function
granted -
US 8008308
Phosphonate compounds
granted -
US 8003693
Modulation of anxiety through blockade of anandamide hydrolysis
granted -
US 7998481
Modulation of NKG2D for treating or preventing solid organ allograft rejection
granted -
US 7998923
Bioactivation of particles
granted -
US 7999079
Therapeutic monoclonal antibodies that neutralize botulinum neurotoxins
granted -
US 7998928
Method of treatment of type-1 diabetes with a humanin analogue
granted -
US 7993865
Diagnosis, prevention and treatment of Crohn's disease using the OmpC antigen
granted -
US 7994226
Methods of treating non-alcoholic steatohepatitis (NASH) using cysteamine products
granted -
US 7993867
Diagnosis, prevention and treatment of crohn's disease using the OmpC antigen
granted -
US 7993866
Diagnosis, prevention and treatment of crohn's disease using the OmpC antigen
granted -
US 7994132
Peptides for treatment of scleroderma
granted -
US 7994143
Metabolically stable alkoxyalkyl esters of antiviral or antiproliferative phosphonates, nucleoside phosphonates and nucleoside phosphates
granted -
US 7985783
Aldehyde tags, uses thereof in site-specific protein modification
granted